Robinin (1 μM/ml) largely attenuated snail and α-SMA expression in Mia-PACA2 and PANC-1, which certified that Robinin can obviously inhibit the conversion progress of EMT in pancreatic cancer (Fig. 5A). This evidence concerns the gene ACTA1 and pancreatic neoplasm.